Detalhe da pesquisa
1.
Plasma hPG80 (Circulating Progastrin) as a Novel Prognostic Biomarker for early-stage breast cancer in a breast cancer cohort.
BMC Cancer
; 23(1): 305, 2023 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37016331
2.
The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia.
Blood
; 117(2): 563-74, 2011 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-20940416
3.
Rapid clearance of rituximab may contribute to the continued high incidence of autoimmune hematologic complications of chemoimmunotherapy for chronic lymphocytic leukemia.
Haematologica
; 98(8): 1259-63, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23716541
4.
TOSO, the Fcmicro receptor, is highly expressed on chronic lymphocytic leukemia B cells, internalizes upon IgM binding, shuttles to the lysosome, and is downregulated in response to TLR activation.
J Immunol
; 187(8): 4040-50, 2011 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21908732
5.
hPG80 (circulating progastrin) as a blood biomarker for high-grade glial tumors: A pilot study.
Front Neurol
; 13: 1073476, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36712425
6.
[hPG80 and cancer: A new blood biomarker in development for patient monitoring]. / hPG80 et cancer : un nouveau biomarqueur sanguin en développement pour le suivi des patients.
Bull Cancer
; 109(6): 707-713, 2022 Jun.
Artigo
em Francês
| MEDLINE | ID: mdl-35597620
7.
hPG80 (Circulating Progastrin), a Novel Blood-Based Biomarker for Detection of Poorly Differentiated Neuroendocrine Carcinoma and Well Differentiated Neuroendocrine Tumors.
Cancers (Basel)
; 14(4)2022 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35205614
8.
Prognostic Value of Plasma hPG80 (Circulating Progastrin) in Metastatic Renal Cell Carcinoma.
Cancers (Basel)
; 13(3)2021 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33498444
9.
A novel method to detect hPG80 (human circulating progastrin) in the blood.
Anal Methods
; 13(38): 4468-4477, 2021 10 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34494619
10.
Fractionated subcutaneous rituximab is well-tolerated and preserves CD20 expression on tumor cells in patients with chronic lymphocytic leukemia.
Haematologica
; 95(2): 329-32, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19679883
11.
The oncogenic and druggable hPG80 (Progastrin) is overexpressed in multiple cancers and detected in the blood of patients.
EBioMedicine
; 51: 102574, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31877416
12.
Lenalidomide-induced upregulation of CD80 on tumor cells correlates with T-cell activation, the rapid onset of a cytokine release syndrome and leukemic cell clearance in chronic lymphocytic leukemia.
Haematologica
; 94(9): 1266-73, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19734418
13.
Targeting the Wnt Pathway and Cancer Stem Cells with Anti-progastrin Humanized Antibodies as a Potential Treatment for K-RAS-Mutated Colorectal Cancer.
Clin Cancer Res
; 23(17): 5267-5280, 2017 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28600477
14.
Harnessing the fcµ receptor for potent and selective cytotoxic therapy of chronic lymphocytic leukemia.
Cancer Res
; 74(24): 7510-7520, 2014 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25344228
15.
Anti-leukemia activity of MS-275 histone deacetylase inhibitor implicates 4-1BBL/4-1BB immunomodulatory functions.
PLoS One
; 4(9): e7085, 2009 Sep 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-19759901
16.
Active transcription of the human FASL/CD95L/TNFSF6 promoter region in T lymphocytes involves chromatin remodeling: role of DNA methylation and protein acetylation suggest distinct mechanisms of transcriptional repression.
J Biol Chem
; 281(21): 14719-28, 2006 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-16595663
17.
Rituximab: therapeutic benefit! Vitamin R?
Semin Hematol
; 47(2): 105-6, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20350656